Return to Intended Oncologic Therapy in Patients With Metastatic Non–Small Cell Lung Cancer Discharged to a Skilled Nursing Facility
The number of patients who return to intended oncologic therapy is low, varying by therapy type and performance status. Few have subsequent disease response or stability, with many patients receiving therapy in the last 30 days of life or dying in the hospital.
Authors
- Nathan A. Pennell (ORCID: https://orcid.org/0000-0002-1458-0064)
- Renato V. Samala (ORCID: https://orcid.org/0000-0002-2950-7708)
- Anirudh Yalamanchali (ORCID: https://orcid.org/0000-0002-7216-2282)
- Ali Mushtaq (ORCID: https://orcid.org/0000-0003-1939-1665)
- Preeyal Patel (ORCID: https://orcid.org/0000-0002-2067-3208)
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1200/op-25-00429
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00